Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Opiant Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
OPNT is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 0
- −36 vs. Q4 2022
- Shares held
- 0
- −2.13M (−100.0%) vs. Q4 2022
- Total value
- $0
- −$43.2M (−100.0%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 36
- 0 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Western Standard LLC | 0 | $0 | 0.00% | −424,080−100.0% | Sold out |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −214,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −197,652−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −190,773−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −146,415−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −136,814−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −100,209−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −61,912−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −61,349−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −59,943−100.0% | Sold out |
| Ramius Advisors LLC | 0 | $0 | 0.00% | −55,298−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −54,371−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −48,591−100.0% | Sold out |
| Black Maple Capital Management LP | 0 | $0 | 0.00% | −48,548−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −43,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −42,300−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −39,425−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −38,679−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −37,119−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −16,085−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,169−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,550−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,802−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,070−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −744−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |